C
ARCT icon

Covestor’s Arcturus Therapeutics ARCT Stock Holding History

Covestor’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
42
+30
+250% +$236 ﹤0.01% 2468
2026
Q1 		$0 Buy
12
+7
+140% +$51 ﹤0.01% 2233
2025
Q4 		$0 Hold
5
– – ﹤0.01% 2239
2025
Q3 		$0 Hold
5
– – ﹤0.01% 2254
2025
Q2 		$0 Hold
5
– – ﹤0.01% 2177
2025
Q1 		$0 Buy
5
+3
+150% +$48 ﹤0.01% 2186
2024
Q4 		$0 Hold
2
– – ﹤0.01% 2204
2024
Q3 		$0 Hold
2
– – ﹤0.01% 2182
2024
Q2 		$0 Hold
2
– – ﹤0.01% 2214
2024
Q1 		$0 Sell
2
-1,445
-100% -$51.2K ﹤0.01% 2205
2023
Q4 		$46K Buy
+1,447
New +$34.4K 0.03% 887

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Covestor's ARCT Position: Q2 2026 in Review

Covestor increased its Arcturus Therapeutics (ARCT) stake by 250% in Q2 2026, buying an estimated $236 and bringing the position to 42 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2468.

Covestor first reported a position in ARCT in Q4 2023 and has held it in 11 quarters since. The position peaked at $46K in Q4 2023. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Covestor held 42 shares of Arcturus Therapeutics worth $0 as of Q2 2026.
  • Covestor bought 30 Arcturus Therapeutics shares in Q2 2026, an estimated $236.
  • Arcturus Therapeutics made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2468 holding.
  • Covestor first reported a position in Arcturus Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • Covestor's Arcturus Therapeutics position peaked at $46K in Q4 2023.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.